Odyssey Therapeutics, Inc. (ODTX) Income Statement

12 Followers

Odyssey Therapeutics, Inc. Income Statement

Last quarter (Q2 2026), Odyssey Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q2, Odyssey Therapeutics, Inc.'s net income was $-52.79M. See Odyssey Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25
Total Revenue	$ 2.98M
Gross Profit	$ 2.98M
Operating Expenses	$ 164.13M
Depreciation and Amortization	$ 4.91M
EBITDA	$ -144.65M
Operating Income	$ -161.16M
Other Income/Expenses	$ 11.58M
Pretax Income	$ -149.57M
Net Income	$ -148.65M
Per Share Metrics
Basic EPS	$ -5.39
Diluted EPS	$ -5.39
Weighted Average Shares Outstanding	27.56M
Weighted Average Shares Outstanding (Diluted)	27.56M

Currency in USD

Odyssey Therapeutics, Inc. (ODTX) Income Statement

Odyssey Therapeutics, Inc. Income Statement

Odyssey Therapeutics, Inc. Earnings and Revenue History